Cargando…

Improved Survival after Transarterial Radioembolisation for Hepatocellular Carcinoma Gives the Procedure Added Value

Background: Transarterial Radioembolisation (TARE) requires multidisciplinary experience and skill to be effective. The aim of this study was to identify determinants of survival in patients with hepatocellular carcinoma (HCC), focusing on learning curves, technical advancements, patient selection a...

Descripción completa

Detalles Bibliográficos
Autores principales: Mosconi, Cristina, Cappelli, Alberta, Pettinato, Cinzia, Cocozza, Maria Adriana, Vara, Giulio, Terzi, Eleonora, Morelli, Maria Cristina, Lodi Rizzini, Elisa, Renzulli, Matteo, Modestino, Francesco, Serenari, Matteo, Bonfiglioli, Rachele, Calderoni, Letizia, Tabacchi, Elena, Cescon, Matteo, Morganti, Alessio Giuseppe, Trevisani, Franco, Piscaglia, Fabio, Fanti, Stefano, Strigari, Lidia, Cucchetti, Alessandro, Golfieri, Rita
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9781303/
https://www.ncbi.nlm.nih.gov/pubmed/36556085
http://dx.doi.org/10.3390/jcm11247469
_version_ 1784857040989978624
author Mosconi, Cristina
Cappelli, Alberta
Pettinato, Cinzia
Cocozza, Maria Adriana
Vara, Giulio
Terzi, Eleonora
Morelli, Maria Cristina
Lodi Rizzini, Elisa
Renzulli, Matteo
Modestino, Francesco
Serenari, Matteo
Bonfiglioli, Rachele
Calderoni, Letizia
Tabacchi, Elena
Cescon, Matteo
Morganti, Alessio Giuseppe
Trevisani, Franco
Piscaglia, Fabio
Fanti, Stefano
Strigari, Lidia
Cucchetti, Alessandro
Golfieri, Rita
author_facet Mosconi, Cristina
Cappelli, Alberta
Pettinato, Cinzia
Cocozza, Maria Adriana
Vara, Giulio
Terzi, Eleonora
Morelli, Maria Cristina
Lodi Rizzini, Elisa
Renzulli, Matteo
Modestino, Francesco
Serenari, Matteo
Bonfiglioli, Rachele
Calderoni, Letizia
Tabacchi, Elena
Cescon, Matteo
Morganti, Alessio Giuseppe
Trevisani, Franco
Piscaglia, Fabio
Fanti, Stefano
Strigari, Lidia
Cucchetti, Alessandro
Golfieri, Rita
author_sort Mosconi, Cristina
collection PubMed
description Background: Transarterial Radioembolisation (TARE) requires multidisciplinary experience and skill to be effective. The aim of this study was to identify determinants of survival in patients with hepatocellular carcinoma (HCC), focusing on learning curves, technical advancements, patient selection and subsequent therapies. Methods: From 2005 to 2020, 253 patients were treated. TARE results achieved in an initial period (2005–2011) were compared to those obtained in a more recent period (2012–2020). To isolate the effect of the treatment period, differences between the two periods were balanced using “entropy balance”. Results: Of the 253 patients, 68 were treated before 2012 and 185 after 2012. In the second period, patients had an Eastern Cooperative Oncology Group (ECOG) Performance Status (PS) score of 1 (p = 0.025) less frequently, less liver involvement (p = 0.006) and a lesser degree of vascular invasion (p = 0.019). The median overall survival (OS) of patients treated before 2012 was 11.2 months and that of patients treated beginning in 2012 was 25.7 months. After reweighting to isolate the effect of the treatment period, the median OS of patients before 2012 increased to 16 months. Conclusions: Better patient selection, refinement of technique and adoption of personalised dosimetry improved survival after TARE. Conversely, sorafenib after TARE did not impact life expectancy.
format Online
Article
Text
id pubmed-9781303
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-97813032022-12-24 Improved Survival after Transarterial Radioembolisation for Hepatocellular Carcinoma Gives the Procedure Added Value Mosconi, Cristina Cappelli, Alberta Pettinato, Cinzia Cocozza, Maria Adriana Vara, Giulio Terzi, Eleonora Morelli, Maria Cristina Lodi Rizzini, Elisa Renzulli, Matteo Modestino, Francesco Serenari, Matteo Bonfiglioli, Rachele Calderoni, Letizia Tabacchi, Elena Cescon, Matteo Morganti, Alessio Giuseppe Trevisani, Franco Piscaglia, Fabio Fanti, Stefano Strigari, Lidia Cucchetti, Alessandro Golfieri, Rita J Clin Med Article Background: Transarterial Radioembolisation (TARE) requires multidisciplinary experience and skill to be effective. The aim of this study was to identify determinants of survival in patients with hepatocellular carcinoma (HCC), focusing on learning curves, technical advancements, patient selection and subsequent therapies. Methods: From 2005 to 2020, 253 patients were treated. TARE results achieved in an initial period (2005–2011) were compared to those obtained in a more recent period (2012–2020). To isolate the effect of the treatment period, differences between the two periods were balanced using “entropy balance”. Results: Of the 253 patients, 68 were treated before 2012 and 185 after 2012. In the second period, patients had an Eastern Cooperative Oncology Group (ECOG) Performance Status (PS) score of 1 (p = 0.025) less frequently, less liver involvement (p = 0.006) and a lesser degree of vascular invasion (p = 0.019). The median overall survival (OS) of patients treated before 2012 was 11.2 months and that of patients treated beginning in 2012 was 25.7 months. After reweighting to isolate the effect of the treatment period, the median OS of patients before 2012 increased to 16 months. Conclusions: Better patient selection, refinement of technique and adoption of personalised dosimetry improved survival after TARE. Conversely, sorafenib after TARE did not impact life expectancy. MDPI 2022-12-16 /pmc/articles/PMC9781303/ /pubmed/36556085 http://dx.doi.org/10.3390/jcm11247469 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Mosconi, Cristina
Cappelli, Alberta
Pettinato, Cinzia
Cocozza, Maria Adriana
Vara, Giulio
Terzi, Eleonora
Morelli, Maria Cristina
Lodi Rizzini, Elisa
Renzulli, Matteo
Modestino, Francesco
Serenari, Matteo
Bonfiglioli, Rachele
Calderoni, Letizia
Tabacchi, Elena
Cescon, Matteo
Morganti, Alessio Giuseppe
Trevisani, Franco
Piscaglia, Fabio
Fanti, Stefano
Strigari, Lidia
Cucchetti, Alessandro
Golfieri, Rita
Improved Survival after Transarterial Radioembolisation for Hepatocellular Carcinoma Gives the Procedure Added Value
title Improved Survival after Transarterial Radioembolisation for Hepatocellular Carcinoma Gives the Procedure Added Value
title_full Improved Survival after Transarterial Radioembolisation for Hepatocellular Carcinoma Gives the Procedure Added Value
title_fullStr Improved Survival after Transarterial Radioembolisation for Hepatocellular Carcinoma Gives the Procedure Added Value
title_full_unstemmed Improved Survival after Transarterial Radioembolisation for Hepatocellular Carcinoma Gives the Procedure Added Value
title_short Improved Survival after Transarterial Radioembolisation for Hepatocellular Carcinoma Gives the Procedure Added Value
title_sort improved survival after transarterial radioembolisation for hepatocellular carcinoma gives the procedure added value
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9781303/
https://www.ncbi.nlm.nih.gov/pubmed/36556085
http://dx.doi.org/10.3390/jcm11247469
work_keys_str_mv AT mosconicristina improvedsurvivalaftertransarterialradioembolisationforhepatocellularcarcinomagivestheprocedureaddedvalue
AT cappellialberta improvedsurvivalaftertransarterialradioembolisationforhepatocellularcarcinomagivestheprocedureaddedvalue
AT pettinatocinzia improvedsurvivalaftertransarterialradioembolisationforhepatocellularcarcinomagivestheprocedureaddedvalue
AT cocozzamariaadriana improvedsurvivalaftertransarterialradioembolisationforhepatocellularcarcinomagivestheprocedureaddedvalue
AT varagiulio improvedsurvivalaftertransarterialradioembolisationforhepatocellularcarcinomagivestheprocedureaddedvalue
AT terzieleonora improvedsurvivalaftertransarterialradioembolisationforhepatocellularcarcinomagivestheprocedureaddedvalue
AT morellimariacristina improvedsurvivalaftertransarterialradioembolisationforhepatocellularcarcinomagivestheprocedureaddedvalue
AT lodirizzinielisa improvedsurvivalaftertransarterialradioembolisationforhepatocellularcarcinomagivestheprocedureaddedvalue
AT renzullimatteo improvedsurvivalaftertransarterialradioembolisationforhepatocellularcarcinomagivestheprocedureaddedvalue
AT modestinofrancesco improvedsurvivalaftertransarterialradioembolisationforhepatocellularcarcinomagivestheprocedureaddedvalue
AT serenarimatteo improvedsurvivalaftertransarterialradioembolisationforhepatocellularcarcinomagivestheprocedureaddedvalue
AT bonfigliolirachele improvedsurvivalaftertransarterialradioembolisationforhepatocellularcarcinomagivestheprocedureaddedvalue
AT calderoniletizia improvedsurvivalaftertransarterialradioembolisationforhepatocellularcarcinomagivestheprocedureaddedvalue
AT tabacchielena improvedsurvivalaftertransarterialradioembolisationforhepatocellularcarcinomagivestheprocedureaddedvalue
AT cesconmatteo improvedsurvivalaftertransarterialradioembolisationforhepatocellularcarcinomagivestheprocedureaddedvalue
AT morgantialessiogiuseppe improvedsurvivalaftertransarterialradioembolisationforhepatocellularcarcinomagivestheprocedureaddedvalue
AT trevisanifranco improvedsurvivalaftertransarterialradioembolisationforhepatocellularcarcinomagivestheprocedureaddedvalue
AT piscagliafabio improvedsurvivalaftertransarterialradioembolisationforhepatocellularcarcinomagivestheprocedureaddedvalue
AT fantistefano improvedsurvivalaftertransarterialradioembolisationforhepatocellularcarcinomagivestheprocedureaddedvalue
AT strigarilidia improvedsurvivalaftertransarterialradioembolisationforhepatocellularcarcinomagivestheprocedureaddedvalue
AT cucchettialessandro improvedsurvivalaftertransarterialradioembolisationforhepatocellularcarcinomagivestheprocedureaddedvalue
AT golfieririta improvedsurvivalaftertransarterialradioembolisationforhepatocellularcarcinomagivestheprocedureaddedvalue